Zentalis Pharmaceuticals Inc (NAS:ZNTL)
$ 11.74 -0.33 (-2.73%) Market Cap: 833.69 Mil Enterprise Value: 410.76 Mil PE Ratio: 0 PB Ratio: 1.82 GF Score: 38/100

Zentalis Pharmaceuticals Inc R&D Day (Virtual) Transcript

Dec 16, 2021 / 04:00PM GMT
Release Date Price: $76.57 (-3.42%)
Operator

Greetings, and welcome to the Zentalis R&D Day Event. (Operator Instructions) As a reminder, this conference is being recorded. It is now my pleasure to introduce your host, Dr. Tony Sun, CEO of Zentalis. Thank you, sir. Please go ahead.

Anthony Y. Sun
Zentalis Pharmaceuticals, Inc. - President, CEO & Executive Chairman

Great. Thank you. First, I want to thank everybody for attending the R&D Day at the end of the year. This is something we've been preparing for about half a year and we're very excited to share. First, I'd like to just introduce some of our scientific colleagues that have joined us on this call. And maybe if you can give your brief backgrounds, that would be great. Kwok, can you start?

Kwok;Kin Wong;Anthony Y. Sun

Sure. I'm Kwok Wong. I'm a thoracic medical oncologist. I'm also the Director of Hematology Oncology here at NYU Langone Health, really focusing on looking at novel therapeutics in non-small cell as well as small cell lung cancer.

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot